Serial Number | 88937251 |
Word Mark | ADVRANO |
Filing Date | Thursday, May 28, 2020 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, July 3, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, April 6, 2021 |
Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use |
Translation of Words in Mark | The wording "ADVRANO" has no meaning in a foreign language. |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, June 17, 2020 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Bristol-Myers Squibb Company |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | New York, NY 10016 |
Party Name | Bristol-Myers Squibb Company |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | New York, NY 10016 |
Event Date | Event Description |
Monday, July 3, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, July 3, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
Wednesday, November 30, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, November 28, 2022 | SOU EXTENSION 3 GRANTED |
Monday, November 28, 2022 | SOU EXTENSION 3 FILED |
Monday, November 28, 2022 | TEAS EXTENSION RECEIVED |
Thursday, May 26, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, May 24, 2022 | SOU EXTENSION 2 GRANTED |
Tuesday, May 24, 2022 | SOU EXTENSION 2 FILED |
Tuesday, May 24, 2022 | TEAS EXTENSION RECEIVED |
Friday, December 3, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, December 1, 2021 | SOU EXTENSION 1 GRANTED |
Wednesday, December 1, 2021 | SOU EXTENSION 1 FILED |
Wednesday, December 1, 2021 | TEAS EXTENSION RECEIVED |
Tuesday, June 1, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, April 6, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, April 6, 2021 | PUBLISHED FOR OPPOSITION |
Wednesday, March 17, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, March 2, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, March 1, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, February 26, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, February 26, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, September 1, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, September 1, 2020 | NON-FINAL ACTION E-MAILED |
Tuesday, September 1, 2020 | NON-FINAL ACTION WRITTEN |
Sunday, August 30, 2020 | ASSIGNED TO EXAMINER |
Wednesday, June 17, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, June 1, 2020 | NEW APPLICATION ENTERED |